Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus.
Jereczek-Fossa BA, Marvaso G, Zaffaroni M, Gugliandolo SG, Zerini D, Corso F, Gandini S, Alongi F, Bossi A, Cornford P, De Bari B, Fonteyne V, Hoskin P, Pieters BR, Tree AC, Arcangeli S, Fuller DB, Franzese C, Hannoun-Levi JM, Janoray G, Kerkmeijer L, Kwok Y, Livi L, Loi M, Miralbell R, Pasquier D, Pinkawa M, Scher N, Scorsetti M, Shelan M, Toledano A, van As N, Vavassori A, Zilli T, Pepa M, Ost P; on the behalf of the European Society for Radiotherapy, Oncology Advisory Committee on Radiation Oncology Practice (ESTRO ACROP). Jereczek-Fossa BA, et al. Among authors: pepa m. Cancer Treat Rev. 2021 Jul;98:102206. doi: 10.1016/j.ctrv.2021.102206. Epub 2021 Apr 20. Cancer Treat Rev. 2021. PMID: 33965893 Review.
Effects of MRI image normalization techniques in prostate cancer radiomics.
Isaksson LJ, Raimondi S, Botta F, Pepa M, Gugliandolo SG, De Angelis SP, Marvaso G, Petralia G, De Cobelli O, Gandini S, Cremonesi M, Cattani F, Summers P, Jereczek-Fossa BA. Isaksson LJ, et al. Among authors: pepa m. Phys Med. 2020 Mar;71:7-13. doi: 10.1016/j.ejmp.2020.02.007. Epub 2020 Feb 18. Phys Med. 2020. PMID: 32086149 Clinical Trial.
The emerging role of radiation therapists in the contouring of organs at risk in radiotherapy: analysis of inter-observer variability with radiation oncologists for the chest and upper abdomen.
Arculeo S, Miglietta E, Nava F, Morra A, Leonardi MC, Comi S, Ciardo D, Fiore MS, Gerardi MA, Pepa M, Gugliandolo SG, Livi L, Orecchia R, Jereczek-Fossa BA, Dicuonzo S. Arculeo S, et al. Among authors: pepa m. Ecancermedicalscience. 2020 Jan 6;14:996. doi: 10.3332/ecancer.2020.996. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32153651 Free PMC article.
Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series.
Francia CM, Marvaso G, Piperno G, Gandini S, Ferrari A, Zerella MA, Arculeo S, Sibio D, Fodor C, Pepa M, Trivellato S, Rondi E, Vigorito S, Cattani F, Spaggiari L, De Marinis F, Orecchia R, Ciardo D, Jereczek-Fossa BA. Francia CM, et al. Among authors: pepa m. Neoplasma. 2020 May;67(3):684-691. doi: 10.4149/neo_2020_190717N645. Epub 2020 Mar 18. Neoplasma. 2020. PMID: 32182088
Prognostic significance of neutrophil-to-lymphocyte ratio in HPV status era for oropharyngeal cancer.
Fanetti G, Alterio D, Marvaso G, Gandini S, Rojas DP, Gobitti C, Minatel E, Revelant A, Caroli A, Francia CM, Alessandro O, Pepa M, Gugliandolo SG, Starzyńska A, Polesel J, Vaccher E, Cossu Rocca M, Tagliabue M, Ansarin M, Lupato V, Giacomarra V, De Paoli A, Orecchia R, Franchin G, Jereczek-Fossa BA. Fanetti G, et al. Among authors: pepa m. Oral Dis. 2020 Oct;26(7):1384-1392. doi: 10.1111/odi.13366. Epub 2020 May 13. Oral Dis. 2020. PMID: 32315470
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy.
Jereczek-Fossa BA, Palazzi MF, Soatti CP, Cazzaniga LF, Ivaldi GB, Pepa M, Amadori M, Antognoni P, Arcangeli S, Buffoli A, Beltramo G, Berlinghieri S, Bignardi M, Bracelli S, Bruschieri L, Castiglioni S, Catalano G, Di Muzio N, Fallai C, Fariselli L, Filippi AR, Gramaglia A, Italia C, Lombardi F, Magrini SM, Nava S, Orlandi E, Pasinetti N, Sbicego EL, Scandolaro L, Scorsetti M, Stiglich F, Tonoli S, Tortini R, Valdagni R, Vavassori V, Marvaso G; CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) network. Jereczek-Fossa BA, et al. Among authors: pepa m. Clin Oncol (R Coll Radiol). 2020 Jul;32(7):e160-e161. doi: 10.1016/j.clon.2020.04.007. Epub 2020 Apr 23. Clin Oncol (R Coll Radiol). 2020. PMID: 32354669 Free PMC article. No abstract available.
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy.
Isaksson LJ, Pepa M, Zaffaroni M, Marvaso G, Alterio D, Volpe S, Corrao G, Augugliaro M, Starzyńska A, Leonardi MC, Orecchia R, Jereczek-Fossa BA. Isaksson LJ, et al. Among authors: pepa m. Front Oncol. 2020 Jun 5;10:790. doi: 10.3389/fonc.2020.00790. eCollection 2020. Front Oncol. 2020. PMID: 32582539 Free PMC article. Review.
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Zerini D, Jereczek-Fossa BA, Ciabattoni A, Mirri A, Bertoni F, Fersino S, D'Agostino G, Lohr F, Mortellaro G, Triggiani L, Marvaso G, Pepa M, Cuccia F, Alongi F; Italian Association of Radiotherapy, Clinical Oncology (AIRO). Zerini D, et al. Among authors: pepa m. J Cancer Res Clin Oncol. 2020 Sep;146(9):2311-2317. doi: 10.1007/s00432-020-03297-5. Epub 2020 Jun 24. J Cancer Res Clin Oncol. 2020. PMID: 32583236
Phase II prospective trial "Give Me Five" short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218).
Marvaso G, Gugliandolo SG, Bellerba F, Gandini S, Corrao G, Volpe S, Rojas DP, Riva G, Zerini D, Pepa M, Fodor CI, La Rocca E, Pricolo P, Alessi S, Petralia G, Mistretta FA, Cambria R, Cattani F, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Marvaso G, et al. Among authors: pepa m. Med Oncol. 2020 Jul 28;37(8):74. doi: 10.1007/s12032-020-01397-3. Med Oncol. 2020. PMID: 32725443 Clinical Trial.
62 results